HIRONC

HIRONIC marked the 20th anniversary of its founding on July 12, 2026. The company was established in 2006 as SP Medical, a name derived from "Success Partner," and has since grown into a KOSDAQ-listed developer and manufacturer of medical aesthetic devices with a presence in more than 60 countries.

Two Decades of Development

HIRONIC's founding period (2006–2010) centered on the development of its first medical devices and the establishment of its early patent portfolio. Between 2011 and 2016, the company listed on KOSDAQ and introduced the DOUBLO line of devices, a technology platform later upheld through a defended patent ruling.

From 2017 to 2020, HIRONIC received FDA and CE approvals for multiple device lines, expanding its distribution beyond the Korean market. The period from 2021 to 2023 saw continued growth in international distribution and industry recognition. Most recently, the company has launched SYNERJET PRO™ and MIGLOU™, both of which have received Korea MFDS approvals in 2026.

Current Operations

HIRONIC's product portfolio today includes SYNERJET PRO™, MIGLOU™, New Doublo™ (marketed in Korea as V-RO LIFTING™​), and PICOHI™, covering applications in skin treatment, body contouring, and related aesthetic procedures. The company continues to work with distributors and physicians across its international markets.

In a statement marking the anniversary, HIRONIC said the milestone reflects two decades of work with its distributors, partner physicians, and patients, and that the company intends to continue developing new devices and expanding its international regulatory approvals in the years ahead.​